Trending Stories


From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.

Genetesis Pilot study: 90-second scan shows promise in evaluating chest pain patients in Emergency Department observation unit

Partner News | Published: Thursday, February 13, 2020

Undiagnosed chest pain sends 8-10 million Americans to Emergency Departments annually, making it the second most common complaint. Emergency physicians must rapidly identify patients whose chest pain is cardiac-related. A new pilot study has found that a resting 90-second magnetocardiography (MCG) scan shows promise in evaluating emergency department observation unit (EDOU) chest pain patients for Acute Coronary Artery Syndrome.


MedAxiom Announces Industry Partnership with Genetesis, Inc.

Partner News | Published: Wednesday, February 5, 2020

Genetesis, Inc. is transforming patient care from invasive, stress-induced, lengthy procedures, to non-invasive, at rest, rapid testing.


NextGen Healthcare Announces Partnership with Doctible

Partner News | Published: Monday, February 3, 2020

NextGen Healthcare, Inc., a leading provider of ambulatory-focused technology solutions, announced it has entered into an exclusive partnership with Doctible, a platform that enables healthcare providers to

NextGen Healthcare CEO sounds off on opposition to federal data-sharing rule

Partner News | Published: Monday, February 3, 2020

NextGen Healthcare President and CEO Rusty Frantz sounded off about hospital executives opposing proposed federal data-sharing rules while also sharing data with Silicon Valley tech giants. During a Q&A

ISCHEMIA's Ripple Effects and Where They Leave Cardiologists

Partner News | Published: Monday, February 3, 2020

According to the CDC, heart disease is the leading cause of death worldwide, and coronary artery disease (CAD) is the most common type of heart disease. With such widespread prevalence and risk, accurate

LUMEDX Announces Official HIMSS20 Speakers

Partner News | Published: Friday, January 31, 2020

LUMEDX, a leading provider of healthcare analytics and cardiovascular information systems (CVIS), is pleased to announce that client partner Duke University Health System has been selected to present at the

Congratulations to the IBM Watson Health Top 50 CV Hospitals of 2020

News | Published: Monday, January 13, 2020

In late 2019, IBM Watson Health published its annual list of 50 Top Cardiovascular Hospitals™ in the U.S., one of the leading surveys the CV industry turns to for hospital performance rankings. The 2020 survey, which included nearly 1,000 hospitals across the country with cardiovascular service lines, identified 50 hospitals that “delivered better outcomes while operating more efficiently and at a lower cost.” MedAxiom is proud to be affiliated with nearly half of the top 50 hospitals on the 2020 list.


Are ASCs Ready for CV Procedures in 2020? 6 Insights from 2 Executives

Partner News | Published: Tuesday, January 7, 2020

In an article published in Becker’s ASC Review, two executives from National Cardiovascular Partners, a MedAxiom partner, recently discussed the latest Centers for Medicare and Medicaid Services (CMS) ruling regarding percutaneous coronary interventions in the ambulatory surgical center (ASC) setting for 2020. Read their responses to six questions ranging from ASC preparation for these 2020 CMS rulings to ensuring patient care in ASCs when undergoing these procedures.


12 Days of Resources: 2019 in Review

News | Published: Friday, December 20, 2019

Join us as we countdown the 12 Days of Resources with the most popular MedAxiom resources of 2019.


Cardiovascular Coding Toolkit: Prepare for 2020 Now!

News | Published: Monday, December 9, 2019

2020 is just around the corner and there are numerous coding changes that will go into effect when the 2020 Physician Fee Schedule final rule goes into effect Jan. 1. Brush up on changes and take advantage of MedAxiom resources to ensure you and your practice are set up for success next year.


Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.